BackG1 Therapeutics Overview

G1 Therapeutics Current Assets

G1 Therapeutics's current assets is $93M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$92.92M
33.83% YoYΔ $-47.51M vs prior year quarter

Peer average

Loading

G1 Therapeutics Current Assets History

Loading

G1 Therapeutics vs. peers: Current Assets Comparison

Loading

G1 Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

G1 Therapeutics (GTHX) FAQ

As of the most recent data (June 2024), GTHX shows a current assets of $93M. That compares with $140M in the prior-year period — down 33.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, GTHX's current assets is now $93M (was $140M) — a 33.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether G1 Therapeutics is outperforming or lagging.

Tracking GTHX's current assets over time shows whether G1 Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $93M That compares with $140M in the prior-year period — down 33.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has G1 Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $93M) with ownership activity and broader fundamentals.

G1 Therapeutics's current assets is $93M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.